Welcome ! to Quantum Pharm. Now request quotations in a whole new way. Just put a step forward and request a quote.

FDA Drug Recall Labetalol Injection

Posted by admin 02/27/2018 0 Comment(s)

We have been notified that Hospira has initiated a recall of Labetalol HCl Injection 100 mg/20 ml vial, NDC: 0409-2267-20,

Lot # 74370DD, Exp: 01-Feb-19  

Lot # 75035DD, Exp: 02-Mar-19

Lot # 75115DD, Exp: 01-Mar-19

The recall is due to the discovery of cracks on the rim surface of vial which is covered by the stopper and crimp seal.  Cracked vials may result in a lack of sterility assurance for the product. 

Below is an excerpt from the recall:

Wholesalers/retailers/hospitals/institutions with an existing inventory of the lots subject to this recall should stop use and distribution of the remaining units and quarantine immediately. Healthcare Professionals in your organization should be informed of this recall. If you have further distributed the recalled product, to the wholesale or retail level, please notify any accounts or additional locations which may have received the recalled product from you.

If any additional information is required at this time, please contact us.


Andy Jaskowiak, MS, RPh                                       

Quantum Pharmaceutical Supply & Services, LLC

745 Atlanta Rd Ste 111

Cumming, GA  30040

Leave a Comment